Ortiz-Brizuela Edgar, Villanueva-Reza Marco, González-Lara María F, Tamez-Torres Karla M, Román-Montes Carla M, Díaz-Mejía Bruno A, Pérez-García Esteban, Olivas-Martínez Antonio, Rajme-López Sandra, Martinez-Guerra Bernardo A, de-León-Cividanes Nereyda A, Fernández-García Oscar A, Guerrero-Torres Lorena, Torres-González Lorena, Carrera-Patiño Fabián A, Corral-Herrera Ever A, Hernández-Alemón Aldo N, Tovar-Vargas Maria de Los Á, Serrano-Pinto Yamile G, Espejo-Ortiz Cristian E, Morales-Ortega María de la L, Lozano-Cruz Óscar A, Cárdenas-Fragoso José L, Vidal-Mayo José de J, Hernández-Gilsoul Thierry, Rivero-Sigarroa Eduardo, Domínguez-Cherit Guillermo, Cervantes-Villar Luz E, Ramos-Cervantes Maria Del P, Ibarra-González Violeta, Calva-Mercado Juan J, Sierra-Madero Juan G, López-Íñiguez Álvaro, Ochoa-Hein Eric, Crabtree-Ramírez Brenda E, Galindo-Fraga Arturo, Guerrero-Almeida María de L, Ruiz-Palacios Guillermo M, Gulías-Herrero Alfonso, Sifuentes-Osornio José, Kershenobich-Stalnikowitz David, Ponce-de-León Alfredo
Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Rev Invest Clin. 2020;72(3):165-177. doi: 10.24875/RIC.20000211.
Regional information regarding the characteristics of patients with coronavirus disease (COVID)-19 is needed for a better understanding of the pandemic.
The objective of the study to describe the clinical features of COVID-19 patients diagnosed in a tertiary-care center in Mexico City and to assess differences according to the treatment setting (ambulatory vs. hospital) and to the need of intensive care (IC).
We conducted a prospective cohort, including consecutive patients with COVID-19 from February 26, 2020 to April 11, 2020.
We identified 309 patients (140 inpatients and 169 outpatients). The median age was 43 years (interquartile range, 33-54), 59.2% men, and 18.6% healthcare workers (12.3% from our center). The median body mass index (BMI) was 29.00 kg/m and 39.6% had obesity. Compared to outpatients, inpatients were older, had comorbidities, cough, and dyspnea more frequently. Twenty-nine (20.7%) inpatients required treatment in the IC unit (ICU). History of diabetes (type 1 or 2) and abdominal pain were more common in ICU patients compared to non-ICU patients. ICU patients had higher BMIs, higher respiratory rates, and lower room-air capillary oxygen saturations. ICU patients showed a more severe inflammatory response as assessed by white blood cell count, neutrophil and platelet count, C-reactive protein, ferritin, procalcitonin, and albumin levels. By the end of the study period, 65 inpatients had been discharged because of improvement, 70 continued hospitalized, and five had died.
Patients with comorbidities, either middle-age obese or elderly complaining of fever, cough, or dyspnea, were more likely to be admitted. At admission, patients with diabetes, high BMI, and clinical or laboratory findings consistent with a severe inflammatory state were more likely to require IC.
为了更好地了解新冠疫情,需要有关冠状病毒病(COVID)-19患者特征的地区信息。
本研究的目的是描述在墨西哥城一家三级护理中心诊断出的COVID-19患者的临床特征,并根据治疗环境(门诊 vs. 住院)和重症监护需求评估差异。
我们进行了一项前瞻性队列研究,纳入了2020年2月26日至2020年4月11日连续的COVID-19患者。
我们确定了309例患者(140例住院患者和169例门诊患者)。中位年龄为43岁(四分位间距,33 - 54岁),男性占59.2%,医护人员占18.6%(其中12.3%来自我们中心)。中位体重指数(BMI)为29.00 kg/m,39.6%的患者患有肥胖症。与门诊患者相比,住院患者年龄更大,更频繁地患有合并症、咳嗽和呼吸困难。29例(20.7%)住院患者需要在重症监护病房(ICU)接受治疗。与非ICU患者相比,ICU患者中1型或2型糖尿病病史和腹痛更为常见。ICU患者的BMI更高、呼吸频率更高、室内空气下毛细血管血氧饱和度更低。通过白细胞计数、中性粒细胞和血小板计数、C反应蛋白、铁蛋白、降钙素原和白蛋白水平评估,ICU患者表现出更严重的炎症反应。到研究期结束时,65例住院患者因病情好转已出院,70例仍住院,5例死亡。
患有合并症的患者,无论是中年肥胖者还是主诉发热、咳嗽或呼吸困难的老年人,更有可能入院。入院时,患有糖尿病、高BMI以及临床或实验室检查结果与严重炎症状态相符的患者更有可能需要重症监护。